• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CXb00163 盐酸帕罗西汀片 paroxetine hydrochloride Tablet Chemical Drugs(5) Supplementary Application 2000-12-01 中美天津史克制药有限公司 Sino-American Tianjin SmithKline and French Lab Ltd Certificate Issued 2001-05-23 view
CXHL0600029 盐酸帕罗西汀片 paroxetine hydrochloride Tablet Chemical Drugs(3.4) New Drug Application 2006-02-24 中美天津史克制药有限公司 Sino-American Tianjin SmithKline and French Lab Ltd Certificate Issued 2007-04-25 view
CXHL1100383 盐酸帕罗西汀片 paroxetine hydrochloride Tablet Chemical Drugs(3.4) New Drug Application 2011-08-22 中美天津史克制药有限公司 Sino-American Tianjin SmithKline and French Lab Ltd Certificate Issued 2013-07-09 view
CXL00483 盐酸帕罗西汀片 paroxetine hydrochloride Tablet Chemical Drugs(4) New Drug Application 2000-09-28 四川抗菌素工业研究所、浙江尖峰药业有限公司 view
CYHB0601395 盐酸帕罗西汀片 paroxetine hydrochloride Tablet Chemical Drugs Supplementary Application 2006-08-10 浙江华海药业股份有限公司 Zhe JIANG HUA HAI Pharmaceutical Co Ltd Certificate Issued 2007-04-13 view
CYHB0807120 盐酸帕罗西汀片 paroxetine hydrochloride Tablet Chemical Drugs Supplementary Application 2008-09-17 中美天津史克制药有限公司 Sino-American Tianjin SmithKline and French Lab Ltd Certificate Issued 2009-10-22 view
CYHB0810989 盐酸帕罗西汀片 paroxetine hydrochloride Tablet Chemical Drugs Supplementary Application 2009-02-04 浙江华海药业股份有限公司 Zhe JIANG HUA HAI Pharmaceutical Co Ltd Certificate Issued 2009-08-05 view
CYHB0811727 盐酸帕罗西汀片 paroxetine hydrochloride Tablet Chemical Drugs Supplementary Application 2009-03-25 浙江尖峰药业有限公司 Zhejiang Jianfeng Pharmaceutical Macutical Holdings Certificate Issued 2010-06-02 view
CYHB0811958 盐酸帕罗西汀片 paroxetine hydrochloride Tablet Chemical Drugs Supplementary Application 2009-02-04 浙江尖峰药业有限公司 Zhejiang Jianfeng Pharmaceutical Macutical Holdings Certificate Issued 2010-03-04 view
CYHB1014715 盐酸帕罗西汀片 paroxetine hydrochloride Tablet Chemical Drugs Supplementary Application 2010-12-24 中美天津史克制药有限公司 Sino-American Tianjin SmithKline and French Lab Ltd Certificate Issued 2011-06-03 view
CYHB1101514 盐酸帕罗西汀片 paroxetine hydrochloride Tablet Chemical Drugs Supplementary Application 2011-03-22 浙江尖峰药业有限公司 Zhejiang Jianfeng Pharmaceutical Macutical Holdings Certificate Issued 2013-08-09 view
CYHB1190001 盐酸帕罗西汀片 paroxetine hydrochloride Tablet Chemical Drugs Supplementary Application 2011-01-05 浙江华海药业股份有限公司 Zhe JIANG HUA HAI Pharmaceutical Co Ltd Certificate Issued 2012-09-11 view
CYHB1506311 盐酸帕罗西汀片 paroxetine hydrochloride Tablet Chemical Drugs Supplementary Application 2015-09-18 北京万生药业有限责任公司 Beijing Foyou Pharma Co Ltd Certificate Issued 2016-08-01 view
CYHB1703361 盐酸帕罗西汀片 paroxetine hydrochloride Tablet Chemical Drugs Supplementary Application 2017-07-18 浙江华海药业股份有限公司 Zhe JIANG HUA HAI Pharmaceutical Co Ltd Certificate Issued 2017-12-29 view
CYHB1703557 盐酸帕罗西汀片 paroxetine hydrochloride Tablet Chemical Drugs Supplementary Application 2018-01-15 中美天津史克制药有限公司 Sino-American Tianjin SmithKline and French Lab Ltd Certificate Issued 2018-06-28 view
CYHB1850191 盐酸帕罗西汀片 paroxetine hydrochloride Tablet Chemical Drugs Supplementary Application 2018-09-19 中美天津史克制药有限公司 Sino-American Tianjin SmithKline and French Lab Ltd Certificate Issued 2019-11-28 view
CYHB1850347 盐酸帕罗西汀片 paroxetine hydrochloride Tablet Chemical Drugs Supplementary Application 2018-11-21 北京万生药业有限责任公司 Beijing Foyou Pharma Co Ltd Certificate Issued 2019-09-19 view
CYHB1950106 盐酸帕罗西汀片 paroxetine hydrochloride Tablet Chemical Drugs Supplementary Application 2019-02-15 浙江尖峰药业有限公司 Zhejiang Jianfeng Pharmaceutical Macutical Holdings Certificate Issued 2020-03-06 view
CYHB2006936 盐酸帕罗西汀片 paroxetine hydrochloride Tablet Chemical Drugs Supplementary Application 2020-09-17 中美天津史克制药有限公司 Sino-American Tianjin SmithKline and French Lab Ltd Certificate Issued 2020-11-12 view
CYHB2101151 盐酸帕罗西汀片 paroxetine hydrochloride Tablet Chemical Drugs Supplementary Application 2021-04-23 view